Legal
Medical disclaimer
This site answers one question: what does it cost. It does not answer whether you should take it, which one, or at what dose — and a cheap price on a board here is never a signal that something is safe or right for you.
Last updated
Section 1
What this site is for
Doseworth reads what telehealth companies and pharmacies charge, records it with the date and the page it came from, and works out what the same treatment costs over a full year rather than over a promotional first month. That is the expertise on offer here: money, billing structures, and the gap between an advertised number and a real one.
It is not clinical expertise, and this site does not pretend otherwise. We do not examine, test, diagnose, prescribe, dispense, compound or sell anything. We have no laboratory, we run no assays, and no page here reports a product we tested.
Section 2
No clinician–patient relationship
Reading this site, emailing us, or following one of our links to a provider creates no clinician–patient relationship, and nobody at Doseworth is treating you. We cannot see your history, your labs, your other medications, or anything else that determines whether a treatment is appropriate for you — and those are exactly the inputs the decision turns on.
If you have a condition, a symptom, or a question about a medicine, the person to ask is a licensed physician, nurse practitioner, physician assistant or pharmacist. Never disregard professional advice, or delay getting it, because of something you read here.
Section 3
Compounded semaglutide and tirzepatide
A large share of the cheapest prices on this site are for compounded preparations, so this needs to be unambiguous.
Compounded semaglutide and compounded tirzepatide are not FDA-approved products. FDA approval attaches to a specific finished product, made by a specific manufacturer, to a specific formulation, that has been through the agency's review of safety and effectiveness. A compounded preparation is not that product, has not been through that review, and is not covered by that approval — even when it contains the same named active ingredient as a drug that has been approved.
A compounding pharmacy is not “FDA-approved” either. FDA does not approve pharmacies; it approves drug products. A pharmacy may be licensed by its state board, and an outsourcing facility may be registered with FDA and subject to its inspection — but neither of those facts makes anything the pharmacy compounds an approved drug, and neither is interchangeable with approval. If you see the two blurred together in marketing copy, they are two different things and only one of them is being claimed.
What follows practically: compounded preparations are not required to carry the approved product's labeling, potency and content can vary between facilities, and the regulatory position on compounding particular drugs moves over time. None of that is an accusation against any specific pharmacy or provider. It is a description of the category, and it is a set of questions to raise with your prescriber and with the provider directly.
Section 4
A price is not a recommendation
Our boards sort by price. The row at the top is the cheapest walk-away price we recorded, and that is the entire meaning of its position. It is not our pick, not a safety ranking, not a quality judgment, and not a suggestion that you should use that provider or take that compound.
Cheap and appropriate are unrelated axes. The cheapest option on a board may be the wrong drug for you, the wrong dose ladder for you, or something you should not take at all. Cost is one input into a decision that also involves your medical history, your other medicines, your tolerance for side effects, and the judgment of someone qualified to weigh them.
Section 5
Doses, and the arithmetic around them
Prices on this site are frequently tied to a dose tier, because that is how providers bill: a milligram strength is a price bracket in their pricing table, so it appears in ours. Any number we publish alongside a dose is a description of what a provider charges, or arithmetic performed on that charge.
It is never a dosing instruction. Doseworth does not tell anyone what dose to take, when to escalate, when to hold, or how to convert between products. Those are prescribing decisions, and they belong to your clinician and the approved labeling — not to a pricing table.
Section 6
These are serious medicines
GLP-1 receptor agonists and related metabolic treatments have real risks. The approved labeling for these products carries a boxed warning, sets out contraindications, and documents adverse reactions and interactions in detail. Suitability differs person to person, and so do outcomes: results published in a clinical trial describe a population under trial conditions, not a promise about you.
Read the labeling for whatever you are actually prescribed, and raise your history and your other medicines with the prescriber before you start. If you are considering stopping something, that is also a clinical decision and not a budgeting one.
- Not medical advice
- Nothing on this site is a diagnosis, a treatment plan, or a recommendation to take or avoid any product.
- Not a safety assessment
- We do not test products, inspect facilities, or evaluate clinical quality. Ordering on our boards is price order.
- Not a substitute for labeling
- The approved label for the product you are prescribed governs. Our summaries never replace reading it.
- Not a coverage determination
- Whether your plan pays is decided by your insurer, not by anything published here.
Section 7
Emergencies
If you think you may be having a medical emergency, call 911 or your local emergency number, or go to an emergency department now. Do not email us, and do not wait on a provider's message queue. This site is not monitored for anything urgent and cannot help you in an emergency.
Section 8
Third-party claims and links
We quote and link to providers, manufacturers, FDA correspondence and published research. Quoting a provider's marketing claim — including on our FDA warning-letter pages, where the point is to show you what was said — is reporting, not endorsement. We do not adopt any claim we quote, and a claim appearing on this site is not a claim we have verified clinically.
Section 9
Accuracy, currency, and limits
Regulatory status, availability and clinical guidance all change. We date what we publish so you can see how fresh it is, and we correct what we get wrong — the procedure is on the corrections page — but no publication is a substitute for current professional advice. Your use of anything here is at your own risk; the formal limits are in the terms of use.
Section 10
Contact
editor@doseworth.com. We can help with a price, a source, or a correction. We cannot answer a clinical question, and we will not try.